| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $1.81 (Beat by $0.46) |
| EPS GAAP Actual | $1.81 (Beat by $0.46) |
| Revenue Actual | $0.841B |
| Revenue Surprise | Beat by $841M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 10.08183 | 9.89 | 9.38528 | 10.69268 | 2 |
| Dec 2027 | 7.08 | 14.09 | 6.62117 | 7.53703 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.37 | 1.37 | 0.841B | 2.85% | 841M |
| FQ2 2025 (Jun 2025) | 1.12 | 1.12 | 0.809B | -1.11% | 809M |
| FQ1 2025 (Mar 2025) | 0.97 | 0.97 | 0.774B | 2.33% | 774M |
| FQ4 2024 (Dec 2024) | 1.22 | 1.22 | 0.797B | 3.39% | 797M |
| FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 0.817B | 10.53% | 817M |
| FQ2 2024 (Jun 2024) | 0.91 | 0.91 | 0.818B | 10.64% | 818M |
| FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 0.756B | 11.38% | 756M |
| FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 0.77B | 100% | 770M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.22657 | -- | 2.16051 | 2.29282 | 1 |
| FQ3 2027 (Sep 2027) | 2.03288 | -- | 1.97257 | 2.09336 | 1 |
| FQ2 2027 (Jun 2027) | 2.0828 | -- | 2.02101 | 2.14477 | 1 |
| FQ1 2027 (Mar 2027) | 1.77405 | -- | 1.72142 | 1.82683 | 1 |
| FQ4 2026 (Oct 2026) | 1.98564 | -- | 1.91071 | 2.04006 | 3 |
| FQ3 2026 (Jul 2026) | 1.88823 | 27.45 | 1.81698 | 1.93998 | 3 |
| FQ2 2026 (Jun 2026) | 1.63936 | 31.68 | 1.59072 | 1.68813 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.98B | -- | 0.96B | 1.01B | 1 |
| FQ3 2027 (Sep 2027) | 0.95B | -- | 0.93B | 0.97B | 1 |
| FQ2 2027 (Jun 2027) | 0.96B | -- | 0.94B | 0.98B | 1 |
| FQ1 2027 (Mar 2027) | 0.92B | -- | 0.9B | 0.94B | 1 |
| FQ4 2026 (Oct 2026) | 0.96B | -- | 0.93B | 0.98B | 4 |
| FQ3 2026 (Jul 2026) | 0.96B | 12.1 | 0.93B | 0.98B | 5 |
| FQ2 2026 (Jun 2026) | 0.9B | 10.25 | 0.88B | 0.92B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.37 | 1.37 | 100% | |
| FQ2 2025 (Jun 2025) | 1.12 | 1.12 | 100% | |
| FQ1 2025 (Mar 2025) | 0.97 | 0.97 | 100% | |
| FQ4 2024 (Dec 2024) | 1.22 | 1.22 | 100% | |
| FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 100% | |
| FQ2 2024 (Jun 2024) | 0.91 | 0.91 | 100% | |
| FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 100% | |
| FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.84B | $841M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.81B | $809M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.77B | $774M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.8B | $797M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.82B | $817M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.82B | $818M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.76B | $756M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.77B | $770M | 100% |